Project Start
1985-11-30
Project End
1990-11-29
Budget Start
1986-02-28
Budget End
1986-11-29
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Sztein, M B; Tanner, M K; Polotsky, Y et al. (1995) Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J Immunol 155:3987-93
Wasserman, S S; Losonsky, G A; Noriega, F et al. (1994) Kinetics of the vibriocidal antibody response to live oral cholera vaccines. Vaccine 12:1000-3
Wasserman, S S; Kotloff, K L; Losonsky, G A et al. (1993) Immunologic response to oral cholera vaccination in a crossover study: a novel placebo effect. Am J Epidemiol 138:988-93
Murphy, J R (1993) Diarrhoeal disease: current concepts and future challenges. Rapid detection of enteric infections by measurement of enteric pathogen-specific antibody secreting cells in peripheral blood. Trans R Soc Trop Med Hyg 87 Suppl 3:27-30
Hone, D M; Tacket, C O; Harris, A M et al. (1992) Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J Clin Invest 90:412-20
Suharyono; Simanjuntak, C; Witham, N et al. (1992) Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet 340:689-94
Keay, S; Tacket, C O; Murphy, J R et al. (1992) Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 of HIV-1 or infected with HIV-1. AIDS Res Hum Retroviruses 8:1091-8
Herrington, D A; Losonsky, G A; Smith, G et al. (1992) Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells. Vaccine 10:841-6
Savarino, S J; Fasano, A; Robertson, D C et al. (1991) Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model. J Clin Invest 87:1450-5
Dolin, R; Graham, B S; Greenberg, S B et al. (1991) The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med 114:119-27

Showing the most recent 10 out of 25 publications